These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2384974

  • 1. [Eicosanoids and glomerular disease].
    Kuroda M.
    Nihon Rinsho; 1990 Jun; 48(6):1270-5. PubMed ID: 2384974
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C.
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes in glomerular cross-sectional area induced by platelet activating factor.
    de Arriba G, Barrio V, Hernando L, López-Novoa JM, Rodríguez-Puyol D.
    Nephrol Dial Transplant; 1987 May; 2(4):224-7. PubMed ID: 3118261
    [Abstract] [Full Text] [Related]

  • 8. Glomerular platelet-activating factor levels and origin in experimental glomerulonephritis.
    Lianos EA, Zanglis A.
    Kidney Int; 1990 Feb; 37(2):736-40. PubMed ID: 2308260
    [Abstract] [Full Text] [Related]

  • 9. [Hyperfiltration and hyperperfusion of kidney glomeruli: non-immunological factors initiating or accelerating the progression of nephropathy?].
    Kokot F, Kuska J.
    Przegl Lek; 1988 Feb; 45(4):401-5. PubMed ID: 3062677
    [No Abstract] [Full Text] [Related]

  • 10. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
    Yoo J, Schlondorff D, Neugarten J.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):841-4. PubMed ID: 2005583
    [Abstract] [Full Text] [Related]

  • 11. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.
    Livio M, Macconi D, Morigi M, Orisio S, Benigni A, Patrono C, Remuzzi G.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Mar; 17B():828-32. PubMed ID: 2823570
    [No Abstract] [Full Text] [Related]

  • 12. Lipid inflammatory mediators in glomerulonephritis.
    Lianos EA.
    J Lab Clin Med; 1989 May; 113(5):535-6. PubMed ID: 2497217
    [No Abstract] [Full Text] [Related]

  • 13. Glomerular hemodynamics in experimental glomerulonephritis.
    Blantz RC, Gabbai FB, Wilson CB.
    Adv Nephrol Necker Hosp; 1988 May; 17():3-13. PubMed ID: 3124544
    [No Abstract] [Full Text] [Related]

  • 14. Biosynthesis and role of arachidonic acid metabolites in glomerulonephritis.
    Lianos EA.
    Nephron; 1984 May; 37(2):73-7. PubMed ID: 6427642
    [No Abstract] [Full Text] [Related]

  • 15. Tissue factor in crescentic glomerulonephritis.
    McCluskey RT.
    Am J Pathol; 1997 Mar; 150(3):787-92. PubMed ID: 9060816
    [No Abstract] [Full Text] [Related]

  • 16. [Are glomerular hyperfiltration and hyperperfusion involved in the development and progression of nephropathies?].
    Kokot F, Kuska J.
    Z Urol Nephrol; 1988 Jun; 81(6):359-66. PubMed ID: 3063012
    [Abstract] [Full Text] [Related]

  • 17. Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
    Remuzzi G.
    Adv Exp Med Biol; 1989 Jun; 259():221-47. PubMed ID: 2696353
    [No Abstract] [Full Text] [Related]

  • 18. [Metabolism and action mechanisms of eicosanoids and platelet-activating factor in the kidney].
    Watanabe T.
    Nihon Rinsho; 1992 Dec; 50(12):2937-48. PubMed ID: 1337118
    [Abstract] [Full Text] [Related]

  • 19. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.
    Perico N, Delaini F, Tagliaferri M, Abbate M, Cucchi M, Bertani T, Remuzzi G.
    Lab Invest; 1988 Feb; 58(2):163-71. PubMed ID: 3123798
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms underlying the anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. Inhibited release of a monocyte chemoattractant by glomeruli.
    Rovin BH, Lefkowith JB, Schreiner GF.
    J Immunol; 1990 Aug 15; 145(4):1238-45. PubMed ID: 2116479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.